Skip to main content
Premium Trial:

Request an Annual Quote

BCW Index Barely Budges as Fisher Drops Out

The BCW Index rose .1 percent for the trading week ended Tuesday. Fisher Scientific’s shares ceased trading last week upon closure of its merger with Thermo Electron (see related article), leaving the Index with 15 companies.
 
Molecular Devices led the six firms whose shares gained ground during the week, closing up 3.7 percent. Qiagen led decliners with a 2.4 percent drop, with most of the decline coming the day after it announced strong third-quarter revenue growth.
 

The Index beat the Nasdaq Bioetch Index, which fell .3 percent for the week. But it trailed the broader Nasdaq, which rose 2.3 percent, and the Dow Jones Industrial Average, which climbed .5 percent and closed at its highest level ever on Tuesday.

 
BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Current Price
(November 14, 2006)
Last
Price
(November 7, 2006)
% change
Agilent A
33.00
33.63
-1.9
Applied Biosystems ABI
37.57
38.20
-1.6
Beckman BEC
59.75
60.82
-1.8
Bio-Rad BIO
78.52
76.38
2.8
Bruker BRKR
8.00
7.87
1.7
GE GE
35.59
35.54
0.1
Invitrogen IVGN
57.09
57.38
-0.5
Millipore MIL
66.41
66.78
-0.6
Molecular Devices MDCC
20.73
20.00
3.7
PerkinElmer PKI
21.64
21.70
-0.3
Qiagen QGEN
15.60
15.99
-2.4
Sigma SIAL
77.42
76.16
1.7
Stratagene STGN
6.71
6.83
-1.8
Thermo TMO
43.71
44.36
-1.5
Waters WAT
51.04
50.52
1.0
BCW Index Average  
40.85
40.81
0.1
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.